HYPERAKTIVE PIGGYBAC-TRANSPOSASEN
European patent · EP2401367 · In force
Register entry
- Publication number
- EP2401367
- Application number
- EP10746822
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 25, 2010
- Published
- Jan 4, 2012
- Granted
- Nov 30, 2016
- Protection ends at the latest
- Feb 24, 2030
- Next annual fee due
- Feb 28, 2027
- IPC classes
- C12N 9/22 (2006.01)
- Priority
- US 155804 P 26.02.2009
- PCT application
- PCT/US2010/025380 25.02.2010
- PCT publication
- WO2010/099296 02.09.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Mar 4, 2025
Change
Published in Swissreg on 04.03.2025
- Mar 1, 2024
Change
Published in Swissreg on 01.03.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Jun 2, 2017
Transferred
- Owner
- Transposagen Biopharmaceuticals, Inc., 201 West Second Street, Lexington, KY 40507, USA → Poseida Therapeutics, Inc., 3210 Merryfield Row, San Diego, CA 92121, USA
Published in Swissreg on 02.06.2017
- Jun 2, 2017
Agent entered
- Representative
- BOHEST AG, Holbeinstrasse 36-38, 4051 Basel
Published in Swissreg on 02.06.2017
- Nov 30, 2016
Granted
Published in Swissreg on 30.11.2016
Parties
Inventor
OSTERTAG, Eric
Lexington, KY 40511, US
MADISON, Blair
Philadelphia, PA 19103, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.